Our validated resins can handle endotoxin loads exceeding 900000 EU/mL, ensuring even the most contaminated lysates are purified to clinical standards.
Endotoxins are the most prevalent pyrogens in biopharmaceutical production. Even at picogram levels, these molecules can trigger severe systemic inflammation, fever, and organ failure in humans, making their removal a non-negotiable requirement for injectable therapeutics. Ion Exchange Chromatography (IEX) has emerged as the industry's most robust and scalable solution for depyrogenation. Unlike traditional methods such as ultrafiltration, which struggle when endotoxin aggregates are similar in size to the target protein, IEX exploits the fundamental electrostatic properties of the LPS molecule to achieve high-resolution separation. At Creative Biolabs, we utilize this technology to provide a polishing step that ensures your final product is both safe and stable.
The success of IEX in removing endotoxins lies in the unique chemical structure of the LPS molecule. Endotoxins possess a strong negative charge across a wide pH range due to the presence of phosphate and carboxyl groups in the lipid A and core polysaccharide regions.
Ion Exchange Chromatography (IEX) is a cornerstone technology in downstream bioprocessing, specifically valued for its ability to reduce endotoxin levels to the extremely low thresholds required for clinical safety. Creative Biolabs' IEX platform is engineered to overcome the common pitfalls of standard chromatography.
Our validated resins can handle endotoxin loads exceeding 900000 EU/mL, ensuring even the most contaminated lysates are purified to clinical standards.
We utilize primary amine ligands that maintain high affinity for endotoxins even in high-conductivity buffers, eliminating the need for time-consuming sample dilution.
By transitioning from bead-based resins to membrane chromatography, we utilize convective flow to process samples up to 10-20 times faster, reducing the duration of the purification cycle significantly.
Our protocols involve step-change pH adjustments to abolish the attraction between proteins and endotoxins, ensuring recovery rates of >95%.
Creative Biolabs offers a specialized endotoxin removal service tailored to the needs of researchers and biomanufacturers. We provide a scientifically optimized environment that addresses the interfering factors specific to your molecule. Whether you are dealing with recombinant proteins, vaccines, or complex antibodies, our team ensures a high clearance efficiency. Our structured workflow is designed for transparency and reproducibility, ensuring every project follows a rigorous scientific path.
Workflow of Our Endotoxin Removal Service by Ion Exchange Chromatography.
Creative Biolabs provides industry-leading endotoxin removal by ion exchange chromatography, leveraging salt-tolerant ligands, high-capacity resins, and expert buffer engineering to deliver therapeutic-grade purity with exceptional yields. Our service helps you obtain high-purity recombinant proteins and accelerate your drug discovery process. Contact us to help you design a custom purification strategy.
Yes. While hydrophobic proteins often bind LPS tightly, we utilize dissociation buffers and salt-tolerant membranes to separate the molecules effectively without compromising the protein's fold.
Our flow-through strategies are specifically designed to maximize yield.
We monitor the breakthrough curve of the resin to ensure we never exceed the validated binding capacity, keeping the endotoxin locked to the matrix.
Simply reach out via our inquiry form. We offer a preliminary assessment of your protein's sequence and initial endotoxin load to suggest the best path forward.